Literature DB >> 17987924

M. Deborrah Hyde, MD, MS: the second African-American female neurosurgeon.

Shearwood McClelland.   

Abstract

BACKGROUND: A less-publicized consequence of the civil rights movement in the mid-20th century is the door of opportunity it provided for African-American women to become neurosurgeons, beginning in 1984 with Alexa I. Canady (University of Minnesota). Unfortunately, the exploits of a contemporary African-American woman neurosurgeon, M. Deborrah Hyde, have remained largely in obscurity. This report details the career and exploits of Hyde, one of the first women to receive neurosurgery training in Ohio.
METHODS: A comprehensive review of pertinent modern and historical records spanning the past century was performed.
RESULTS: Born in 1949 in Laurel, MS, Hyde received her BS with honors from Tougaloo College in 1969 and her MS in biology at Cleveland State University. Despite being told in medical school that she was not qualified to compete with "better-prepared" nonminority students, Hyde received her MD from Case Western Reserve University School of Medicine in 1977, earning election into the Alpha Omega Alpha medical honor society. The next year, she began neurosurgery residency at Case Western under Dr. Robert A. Ratcheson and Dr. Robert F. Spetzler, finishing in 1982 as the program's first female graduate. In 1985, Hyde became the second African-American woman certified by the American Board of Neurological Surgery and in 1991 she established the Beacon of Hope Scholarship Foundation for underprivileged youth. She has subsequently continued a distinguished career in private practice, presently residing in West Hills, CA.
CONCLUSION: Hyde's diligence, perseverance and commitment enabled her to overcome intense sexism and racism to train at Case Western, becoming the second African-American woman neurosurgeon and the third woman trained in Ohio (first and second of which were Carole Miller and Janet Bay). As the first woman to train under Ratcheson and Spetzler, her determination, excellence and generosity continue to inspire people of all races.

Entities:  

Mesh:

Year:  2007        PMID: 17987924      PMCID: PMC2574399     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  E. Latunde Odeku, M.D., F.A.C.S., F.I.C.S., 1927-1974. An African pioneer neurosurgeon.

Authors:  A Adeloye
Journal:  J Natl Med Assoc       Date:  1975-07       Impact factor: 1.798

2.  Development of the Spitz-Holter valve in Philadelphia.

Authors:  J A Boockvar; W Loudon; L N Sutton
Journal:  J Neurosurg       Date:  2001-07       Impact factor: 5.115

3.  Clarence Sumner Greene, Sr.: the first African-American neurosurgeon.

Authors:  Shearwood McClelland; Kimbra S Harris
Journal:  Neurosurgery       Date:  2006-12       Impact factor: 4.654

4.  The Montreal Neurological Institute: training of the first African-American neurosurgeons.

Authors:  Shearwood McClelland
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

5.  E. Latunde Odeku: the first African-American neurosurgeon trained in the United States.

Authors:  Shearwood McClelland; Kimbra S Harris
Journal:  Neurosurgery       Date:  2007-04       Impact factor: 4.654

6.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

  6 in total
  3 in total

1.  Letter: A Call to Action: Increasing Black Representation in Neurological Surgery.

Authors:  Donald K Detchou; Alvin Onyewuenyi; Vamsi Reddy; Andre Boyke; Nnenna Mbabuike; William W Ashley; Edjah K Nduom
Journal:  Neurosurgery       Date:  2021-04-15       Impact factor: 4.654

2.  Progress of women in neurosurgery.

Authors:  Robert F Spetzler
Journal:  Asian J Neurosurg       Date:  2011-01

Review 3.  Diversity in Neurosurgery.

Authors:  Eliana E Kim; Andrea L Klein; Jean W Lartigue; Shawn L Hervey-Jumper; Gail Rosseau
Journal:  World Neurosurg       Date:  2020-09-03       Impact factor: 2.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.